Synonym: 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl- 2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride; BMY-13754; MJ-13754-1; Serzone
CAS Number: 82752-99-6
Empirical Formula (Hill Notation): C25H32ClN5O2 · HCl
Molecular Weight: 506.47
MDL Number: MFCD00935760
Linear Formula: C25H32ClN5O2 · HCl
Product Type: Chemical
| assay |
≥98% (HPLC) |
| color |
white |
| form |
solid |
| InChI |
1S/C25H32ClN5O2.ClH/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22;/h3-6,8-11,20H,2,7,12-19H2,1H3;1H |
| InChI key |
DYCKFEBIOUQECE-UHFFFAOYSA-N |
| originator |
Bristol-Myers Squibb |
| Quality Level |
100  |
| SMILES string |
O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C(CC)N1CCOC4=CC=CC=C4.Cl |
| solubility |
DMSO: ≥10 mg/mL |
| |
H2O: insoluble |
| storage condition |
desiccated |
| Biochem/physiol Actions: |
Novel antidepressant; mixed 5-HT2A serotonin receptor antagonist/serotonin uptake inhibitor. |
| Features and Benefits: |
This compound was developed by Bristol-Myers Squibb . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: |
10, 50 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| UNSPSC |
12352200 |
